Needham reiterated Buy and $15 target

On October 19, Needham analyst Serge Belanger reiterated Buy and maintained his $15 price target. No old-to-new target change was reported. CRMD closed October 30 at $5.70, down 25.39%; no consensus-versus-actual earnings report fell within the period.